• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与临床实践指南推荐相关的决策辅助工具:一项针对广泛性焦虑障碍患者的决策辅助工具可接受性的研究结果。

Decision aids linked to the recommendations in clinical practice guidelines: results of the acceptability of a decision aid for patients with generalized anxiety disorder.

机构信息

Canary Islands Health Research Institute Foundation, Tenerife, Spain.

Facultad de Ciencias de La Salud - Sección de Psicología, University of La Laguna (ULL), Tenerife, Spain.

出版信息

BMC Med Inform Decis Mak. 2022 Jun 30;22(1):171. doi: 10.1186/s12911-022-01899-2.

DOI:10.1186/s12911-022-01899-2
PMID:35773665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9243714/
Abstract

BACKGROUND

Generalized anxiety disorder (GAD) is one of the most prevalent mental health problems. Patients with GAD have unmet needs related to the information received about their disorder, its treatments and their participation in the decision-making process. The aim of this study is to develop and assess the acceptability of a patient decision aid (PtDA) for patients with GAD.

METHOD

The PtDA was developed following the International Patient Decision Aid Standards. The recommendations of the Spanish clinical practice guideline (CPG) for patients with GAD were used as the basis. The first prototype was developed by an expert committee, further improvements were made with patients (n = 2), clinical experts (n = 13) and the project management group (n = 7). The acceptability of this second draft was assessed by patients non-involved in the previous phases (n = 11).

RESULTS

The final PtDA version included a brief description of GAD and its treatments. Most participants agreed that the PtDA was easy to use, visually appealing and useful. At least half of the participants learned new things about treatments and adverse effects.

CONCLUSIONS

A PtDA was developed for patients with GAD based on recommendations from the Spanish CPG. It was improved and accepted by patients and clinical experts involved. An evaluation of its effectiveness on the shared decision-making process during the clinical encounter is planned.

摘要

背景

广泛性焦虑障碍(GAD)是最常见的心理健康问题之一。GAD 患者在其疾病相关信息、治疗方案以及参与决策过程方面存在未满足的需求。本研究旨在开发并评估 GAD 患者使用的患者决策辅助工具(PtDA)的可接受性。

方法

PtDA 的开发遵循国际患者决策辅助工具标准。GAD 患者的西班牙临床实践指南(CPG)建议被用作开发的基础。由一个专家委员会制定了第一版原型,然后与患者(n=2)、临床专家(n=13)和项目管理小组(n=7)共同对其进行了进一步的改进。之前没有参与过前几个阶段的患者(n=11)对这第二版草案的可接受性进行了评估。

结果

最终的 PtDA 版本包括对 GAD 及其治疗方法的简要描述。大多数参与者认为 PtDA 使用方便、视觉效果好且有用。至少一半的参与者了解到了有关治疗和不良反应的新知识。

结论

基于西班牙 CPG 的建议,为 GAD 患者开发了 PtDA。它得到了参与的患者和临床专家的改进和认可。计划对其在临床就诊期间对共享决策过程的有效性进行评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45b9/9245284/fd4251711a51/12911_2022_1899_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45b9/9245284/ddc4670eedf9/12911_2022_1899_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45b9/9245284/a18c28beee57/12911_2022_1899_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45b9/9245284/0643ae70b26c/12911_2022_1899_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45b9/9245284/fd4251711a51/12911_2022_1899_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45b9/9245284/ddc4670eedf9/12911_2022_1899_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45b9/9245284/a18c28beee57/12911_2022_1899_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45b9/9245284/0643ae70b26c/12911_2022_1899_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45b9/9245284/fd4251711a51/12911_2022_1899_Fig4_HTML.jpg

相似文献

1
Decision aids linked to the recommendations in clinical practice guidelines: results of the acceptability of a decision aid for patients with generalized anxiety disorder.与临床实践指南推荐相关的决策辅助工具:一项针对广泛性焦虑障碍患者的决策辅助工具可接受性的研究结果。
BMC Med Inform Decis Mak. 2022 Jun 30;22(1):171. doi: 10.1186/s12911-022-01899-2.
2
Effectiveness of a web-based decision aid for patients with generalised anxiety disorder: a protocol for a randomised controlled trial.基于网络的广泛性焦虑症患者决策辅助工具的有效性:一项随机对照试验方案
BMJ Open. 2020 Dec 10;10(12):e039956. doi: 10.1136/bmjopen-2020-039956.
3
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs.一种用于启动改善病情抗风湿药物的患者决策辅助工具的评估
Arthritis Res Ther. 2016 Oct 28;18(1):252. doi: 10.1186/s13075-016-1138-3.
4
Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients.新发复发型多发性硬化症患者决策辅助工具的开发与可用性测试
BMC Neurol. 2019 Jul 20;19(1):173. doi: 10.1186/s12883-019-1382-7.
5
Development of an online patient decision aid for kidney failure treatment modality decisions.开发一种在线患者决策辅助工具,用于治疗肾衰竭治疗方式的决策。
BMC Nephrol. 2022 Jul 6;23(1):236. doi: 10.1186/s12882-022-02853-0.
6
Development of a Patient Decision Aid to Support Shared Decision Making for Patients with Recurrent High-Grade Glioma.开发一种患者决策辅助工具,以支持复发性高级别胶质瘤患者的共同决策。
Int J Environ Res Public Health. 2022 Jun 16;19(12):7396. doi: 10.3390/ijerph19127396.
7
Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing.重度抑郁症患者的抗抑郁药决策辅助工具(ADAM):开发与试点测试
Patient Educ Couns. 2022 Jul;105(7):2466-2474. doi: 10.1016/j.pec.2021.11.007. Epub 2021 Nov 20.
8
A 'combined framework' approach to developing a patient decision aid: the PANDAs model.一种用于开发患者决策辅助工具的“综合框架”方法:熊猫模型。
BMC Health Serv Res. 2014 Oct 24;14:503. doi: 10.1186/s12913-014-0503-7.
9
Understanding and meeting information needs for patients with posttraumatic stress disorder.了解并满足创伤后应激障碍患者的信息需求。
BMC Psychiatry. 2016 Feb 1;16:21. doi: 10.1186/s12888-016-0724-x.
10
Development of a patient decision aid for COVID-19 vaccination with the Comirnaty vaccine.《科维希德疫苗 COVID-19 接种患者决策辅助工具的开发》。
Fam Pract. 2022 May 28;39(3):486-492. doi: 10.1093/fampra/cmab156.

引用本文的文献

1
Comparison of analog and digital patient decision aids for the treatment of depression: a scoping review.用于抑郁症治疗的模拟和数字患者决策辅助工具的比较:一项范围综述
Front Digit Health. 2023 Sep 1;5:1208889. doi: 10.3389/fdgth.2023.1208889. eCollection 2023.
2
Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic.一种考虑停用苯二氮䓬类抗焦虑药的焦虑症决策辅助工具的开发与可接受性
Front Psychiatry. 2023 May 12;14:1083568. doi: 10.3389/fpsyt.2023.1083568. eCollection 2023.
3
Correction to: Decision aids linked to the recommendations in clinical practice guidelines: results of the acceptability of a decision aid for patients with generalized anxiety disorder.

本文引用的文献

1
Decision aids linked to evidence summaries and clinical practice guidelines: results from user-testing in clinical encounters.与证据总结和临床实践指南相关的决策辅助工具:临床诊疗中用户测试的结果
BMC Med Inform Decis Mak. 2021 Jun 29;21(1):202. doi: 10.1186/s12911-021-01541-7.
2
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.支持 OMERACT 核心领域集用于风湿病学试验中的共享决策干预:来自多步骤共识建立方法的结果。
Semin Arthritis Rheum. 2021 Jun;51(3):593-600. doi: 10.1016/j.semarthrit.2021.03.017. Epub 2021 Apr 6.
3
对《与临床实践指南中的建议相关的决策辅助工具:广泛性焦虑症患者决策辅助工具的可接受性结果》的更正
BMC Med Inform Decis Mak. 2022 Jul 18;22(1):188. doi: 10.1186/s12911-022-01930-6.
Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care.
构建用于初级保健中治疗单纯性尿路感染的患者决策辅助工具。
BMC Fam Pract. 2021 Jan 26;22(1):26. doi: 10.1186/s12875-021-01374-3.
4
Effectiveness of a web-based decision aid for patients with generalised anxiety disorder: a protocol for a randomised controlled trial.基于网络的广泛性焦虑症患者决策辅助工具的有效性:一项随机对照试验方案
BMJ Open. 2020 Dec 10;10(12):e039956. doi: 10.1136/bmjopen-2020-039956.
5
Framing the process in the implementation of care for people with generalized anxiety disorder in primary care: a qualitative evidence synthesis.在初级保健中实施广泛性焦虑症患者护理的框架:定性证据综合。
BMC Fam Pract. 2020 Nov 20;21(1):237. doi: 10.1186/s12875-020-01307-6.
6
Improving treatment decision-making in bipolar II disorder: a phase II randomised controlled trial of an online patient decision-aid.改善双相情感障碍 II 型的治疗决策:一项在线患者决策辅助工具的 II 期随机对照试验。
BMC Psychiatry. 2020 Sep 17;20(1):447. doi: 10.1186/s12888-020-02845-0.
7
Development of a patient decision aid for treatment resistant depression.治疗抵抗性抑郁症患者决策辅助工具的开发。
J Affect Disord. 2020 Oct 1;275:299-306. doi: 10.1016/j.jad.2020.07.014. Epub 2020 Jul 10.
8
Intolerance of uncertainty and decision making in generalized anxiety disorder patients.广泛性焦虑症患者对不确定性的不耐受与决策制定
Psychiatry Res. 2019 Sep;279:393-394. doi: 10.1016/j.psychres.2019.05.031.
9
Healthcare Options for People Experiencing Depression (HOPE*D): the development and pilot testing of an encounter-based decision aid for use in primary care.抑郁症患者的医疗保健选择(HOPE*D):一种用于初级保健的基于诊疗的决策辅助工具的开发与试点测试
BMJ Open. 2019 Apr 8;9(4):e025375. doi: 10.1136/bmjopen-2018-025375.
10
Continue, adjust, or stop antipsychotic medication: developing and user testing an encounter decision aid for people with first-episode and long-term psychosis.继续、调整或停止抗精神病药物治疗:为首发和长期精神病患者开发和用户测试一种就诊决策辅助工具。
BMC Psychiatry. 2018 May 22;18(1):142. doi: 10.1186/s12888-018-1707-x.